|
Parameter
| |
n
1
a
|
n
2
a
|
P valueb
|
Hazard ratio
|
95% confidence interval
|
|---|
|
Lymphocyte-specific kinase metagene
|
Low vs. high
|
21
|
16
|
0.011
|
4.17
|
1.38 to 12.6
|
|
Lymph node status
|
LNN vs. N1
|
24
|
13
|
0.438
|
0.69
|
0.27 to 1.77
|
|
Age
|
>50 years vs. ≤ 50 years
|
18
|
19
|
0.558
|
1.38
|
0.47 to 4.09
|
|
Pathological grading
|
Poor vs. well/intermediate
|
19
|
18
|
0.097
|
2.27
|
0.86 to 5.99
|
|
Tumor size
|
>2 cm vs. ≤ 2 cm
|
15
|
22
|
0.405
|
1.63
|
0.52 to 5.12
|
- aComplete information on all parameters was available for 37 estrogen receptor-positive human epidermal growth factor receptor 2 (HER2)-positive samples. bSignificant values presented in bold.
